Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 

No cure, significant slowing down of aspects of the disease (seems ot be directed at the heart which in the end is the main reason for death in Duchenne). More effective when the progression of the disease is not advanced, so the younger you get this to kids the better but as of yet it is not available but it seems to be (my words, not theirs) close to coming to market. My guess (2025 +/- a year). I would like to add: beware of the enormous costs when not insured...